on OXURION (EBR:OXUR)
Oxurion Announces Transparency Notification from Atlas Special Opportunities II
On October 28, 2026, Oxurion NV, based in Leuven, Belgium, disclosed the receipt of a transparency notification under Belgian law. This notification, received on October 27, 2026, from Atlas Special Opportunities II, stated that as of October 22, 2026, Atlas held 41,497,561 shares of Oxurion, representing less than 20% of the total 232,004,731 outstanding shares. This indicates a reduction in Atlas's voting securities in Oxurion.
Oxurion, listed on Euronext Brussels as OXUR, focuses on integrating clinical research with software innovation. The company aims to support pharmaceutical, biotechnology, and medical device industries through its proprietary data and clinical operations expertise.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OXURION news